Eliza R. Gomes

Belo Horizonte, MG 31270901, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Hybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles.

Hybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles.

Journal: Pharmaceutics

Published: May 10, 2024

Heating Capacity and Biocompatibility of Hybrid Nanoparticles for Magnetic Hyperthermia Treatment.

Heating Capacity and Biocompatibility of Hybrid Nanoparticles for Magnetic Hyperthermia Treatment.

Journal: International journal of molecular sciences

Published: October 10, 2023

Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines.

Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines.

Journal: Pharmaceutics

Published: December 15, 2022

Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin.

Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin.

Journal: Pharmaceutics

Published: September 20, 2022

Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.

Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer.

Journal: AAPS PharmSciTech

Published: April 05, 2022

Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy.

Combining Nanocarrier-Assisted Delivery of Molecules and Radiotherapy.

Journal: Pharmaceutics

Published: November 24, 2021

Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment.

Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment.

Journal: Frontiers in oncology

Published: October 30, 2020

Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.

Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 20, 2020

Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.

Synthesis and cytotoxicity evaluation of glycosidic derivatives of lawsone against breast cancer cell lines.

Journal: Bioorganic & medicinal chemistry letters

Published: August 09, 2019

Long-circulating and fusogenic liposomes loaded with a glucoevatromonoside derivative induce potent antitumor response.

Long-circulating and fusogenic liposomes loaded with a glucoevatromonoside derivative induce potent antitumor response.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 27, 2018

Breast cancer under age 40: a different approach.

Breast cancer under age 40: a different approach.

Journal: Current treatment options in oncology

Published: March 23, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026